Actively Recruiting
Adapting the FACETS Program to Sickle Cell Disease
Led by Versailles Hospital · Updated on 2025-08-19
24
Participants Needed
2
Research Sites
68 weeks
Total Duration
On this page
Sponsors
V
Versailles Hospital
Lead Sponsor
U
University Hospital, Grenoble
Collaborating Sponsor
AI-Summary
What this Trial Is About
Adaptation of a fatigue management program combining the principles of cognitive-behavioral therapy and energy conservation strategies (FACETS program) for a population of adult patients with sickle cell disease (Drépa-FACETS program).
CONDITIONS
Official Title
Adapting the FACETS Program to Sickle Cell Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participant has freely given oral agreement.
- Participant has major sickle cell syndrome regardless of genotype (e.g., SS, SC, Sbeta).
- Participant has sufficient spoken and written French to complete assessments, questionnaires, follow sessions, and do home exercises.
You will not qualify if you...
- Participant has one or more severe psychiatric conditions (e.g., severe depression, psychosis) that may interfere with the study.
- Participant has another chronic disease causing fatigue.
- Participant is currently in vaso-occlusive crisis or hospitalized.
- Participant is under legal protection (guardianship, curatorship, safeguard of justice) or deprived of liberty.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
CHU Grenoble Alpes
Grenoble, France, 38000
Actively Recruiting
2
Hospital Versailles
Le Chesnay, France, 78150
Completed
Research Team
M
Michalina DANNOUNE
CONTACT
D
Damien OUDIN-DOGLIONI, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
PREVENTION
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here